Skip to content
MMJ Gazette
  Tuesday 5 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal July 30, 2025Starting a Cannabis Business? Here’s What You Really Need to Know First July 29, 2025New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle? July 29, 2025Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate July 28, 2025Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  News  Epsilon Healthcare faces scrutiny amid financial woes and board disputes
NewsCannabis

Epsilon Healthcare faces scrutiny amid financial woes and board disputes

Lars BeckersLars Beckers—February 4, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Epsilon Healthcare, a medical cannabis company, is under significant investigation by its administrators, who are looking into the allegations and disputes that have plagued its board and finances. The administrators, from KordaMentha, have told shareholders that they are conducting a comprehensive review of the company’s affairs and have received various matters from creditors that require further examination.

The administrators were appointed on December 23, 2023, after Epsilon failed to repay a $4 million loan from India Resurgent ARC, an Indian asset reconstruction company. India Resurgent ARC acquired the debt from Epsilon’s former lender, Westpac, in October 2023. Epsilon had claimed that the loan was unlawful and unenforceable and had sought to challenge it in court.

Epsilon

Epsilon’s boardroom battles and legal troubles

Epsilon’s financial troubles were compounded by its boardroom battles and legal troubles, which have been ongoing for months. The company has been embroiled in a power struggle between its former chairman and CEO, Jarrod White, and its largest shareholder, Merchant Funds Management. Merchant Funds Management, which owns 19.9% of Epsilon, had accused White of mismanagement and conflict of interest and had sought to remove him from the board.

White, who resigned as CEO in November 2023, had denied the allegations and launched a counter-attack against Merchant Funds Management, alleging that it had breached the Corporations Act and the ASX Listing Rules by failing to disclose its true intentions and associates. White had also claimed that Merchant Funds Management had colluded with the India Resurgent ARC to force Epsilon into administration.

In addition to the board dispute, Epsilon had also faced legal action from its former partner, THC Global, over a terminated supply agreement. THC Global had sued Epsilon for $2.6 million in damages, alleging that Epsilon had breached the agreement and had misrepresented its ability to produce medical cannabis products. Epsilon had denied the claims and had counter-sued THC Global for $1.5 million, alleging that THC Global had failed to pay for the products it had received.

Epsilon’s prospects and challenges

Epsilon’s administrators have said that they are exploring all possible options for the company’s future, including a deed of company arrangement, a sale of the business or its assets, or a liquidation. They have also said that they are working with the company’s management and staff to maintain its operations and preserve its value.

Epsilon, which was formerly known as THC Pharma, operates a medical cannabis cultivation and manufacturing facility in Queensland, Australia, as well as a network of clinics and telehealth services in Australia and New Zealand. The company had reported a net loss of $5.4 million for the financial year ended June 30, 2023, and had reduced its revenue guidance for the current financial year from $12 million to $8 million.

Epsilon’s prospects and challenges will depend on the outcome of the administrators’ investigations and the creditors’ meeting, which is expected to be held in late February or early March 20242. The company will also have to resolve its board and legal disputes and restore its reputation and credibility in the medical cannabis industry.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Nextleaf Solutions reports stellar financial performance and debt-free status in 2023
Humboldt Cannabis Farmer Fined $750K for Damaging Water and Wildlife
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Businesses Face Tightrope Act as Rules Shift State to State

August 4, 20250
Cannabis

Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves

August 3, 20250
Marijuana

Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E

August 2, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
  • Starting a Cannabis Business? Here’s What You Really Need to Know First
  • New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle?
  • Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate
  • Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors